Discover how much money can be saved in your clinical trial!

Screen Shot 2018 04 19 at 3.41.36 PM

Duplicate Subjects In CNS Clinical Trials and Other Therapeutic Areas Prevented With Verified Clinical Trials Research Subject Database Registry

From phase 1 through phase 4 drug development, the issue of duplicate subjects in clinical trials exists.  Verified Clinical Trials (VCT). www.verifiedclinicaltrials.com is here to prevent these issues and promote safety and data quality.  Duplicate subjects in CNS clinical trials is especially needed, but VCT protects most therapeutic areas. Characteristics of duplicate subjects are not …

Read more

Screen Shot 2019 05 02 at 10.37.54 AM

Strategies to Combat Research Participant Dishonesty/Deception, Non-adherence, and Professional Subjects Using Verified Clinical Trials

Verified Clinical Trials (VCT) will be attending ASCP and will host a panel session: Bad Behavior in Clinical Trials: Strategies to Combat Research Participant Dishonesty/Deception, Non-adherence, and Professional Research Subjects. Verified Clinical Trials prevents duplicate subjects in clinical trials. The largest research subject database registry for CNS clinical trials and all other therapeutic areas #duplicatesubjects …

Read more

Screen Shot 2019 04 30 at 4.03.56 PM

Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data …

Read more

Screen Shot 2019 04 23 at 4.01.09 PM

Research Sites Cooperate To Prevent Duplicate Subjects in CNS Clinical Trials By Using The Verified Clinical Trials Research Subject Registry

Duplicate subjects exist in most clinical trials to varying degrees.  CNS clinical trials are especially  prone to duplicate subject or over enrollment.  The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications.  Use of global research subject database registry such as Verified Clinical Trials will help …

Read more

Screen Shot 2019 04 05 at 3.24.31 PM

Preventing Duplicate Subjects In European Clinical Trials: Average Travel Distance

Verified Clinical Trials (VCT) has been well adopted in many research sites and CROs in several European countries.  Data again proves that research volunteers will travel significant distances to dual enroll in multiple clinical trials contemporaneously. There is a similar experience in the United States whereby duplicate subjects in clinical trials will travel thousands of …

Read more

Screen Shot 2018 05 10 at 10.06.19 PM

CNS Clinical Trials Are Prone To Duplicate Subjects and Duplicate Enrollment

CNS clinical trials, especially psychiatry clinical trials are prone to having duplicate subjects in clinical trials.  In studies that rely upon subjective end points, there exists the ability to provide false information in an effort to gain entry in to the study.  Of course, these occurrences result in failed trials due to elevated placebo rates or issues with safety if the volunteer does in fact take the investigational product (IP) from multiple sites.

Use of the Verified Clinical Trials (VCT) global research subject registry has been quite effective at stopping these issues at the time of screening. The protections continue throughout the entire study.  The Verified Clinical Trials network is expansive and covers multiple countries worldwide.  Nearly every phase 1 unit across the United States and now in Europe and elsewhere.  VCT protects many therapeutic indications but is especially focused on duplicate subjects in CNS clinical trials and duplicate subjects in psychiatry clinical trials.

The data is rather impressive with as preventable protocol violations including duplicate or dual enrollment in clinical trials ranging higher than 10% in some instances.  The National Institute of Health (NIH) uses VCT exclusively.

Screen Shot 2018 03 27 at 8.51.00 PM

Duplicate Subjects In Clinical Trials Prevented By Verified Clinical Trials

Duplicate subjects in clinical trials has attracted the attention of many clinical trial managers and study leads.  To prevent duplicate subjects or professional research subjects, many sponsors have added the use of Verified Clinical Trials (VCT) as a mandatory step during the screening process.  VCT verifies a research subject’s study history at the time of …

Read more

Screenshot 2017 06 03 09.56.26 1

Duplicate Subjects In Clinical Trials Can Be Prevented With A Global Research Subject Registry

Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research.  These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry.  Nearly all of the phase 1 units across the United States …

Read more

Screen Shot 2019 03 31 at 10.34.14 PM

Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic …

Read more

Screen Shot 2018 12 14 at 2.11.38 PM

Combatting The Professional Patient Problem In Clinical Trials

Great article by John Carlos Diaz on the issue of hashtag#professionalresearchsubjects and hashtag#duplicatesubjects https://lnkd.in/eJrFDDF. Use of the Verified Clinical Trials (VCT) prevents this issue at the time of screening and protects throughout the entire study. Easy to implement and cost-effective. Contact VCT at info@verifiedclinicaltrials.com or call +1.516.998.7499